Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Sarepta Therapeutics

Sarepta Therapeutics reported $202.68M in Stock for its fiscal quarter ending in March of 2023.

Stock Change
Acadia Pharmaceuticals ACAD:US USD 6.1M 541K
Alnylam Pharmaceuticals ALNY:US USD 131.88M 2.92M
Amgen AMGN:US USD 5.01B 81M
Biogen BIIB:US USD 1.28B 63.4M
Daiichi Sankyo 4568:JP JPY 301.61B 34.92B
Gilead Sciences GILD:US USD 3.01B 190M
Incyte Corp INCY:US USD 40.88M 80.08M
Intercept Pharmaceuticals ICPT:US USD 6.46M 1000
Moderna Inc MRNA:US USD 732M 217M
Neurocrine Biosciences NBIX:US USD 33.4M 1.7M
Novavax NVAX:US USD 34.18M 2.5M
Regeneron Pharmaceuticals REGN:US USD 2.42B 22.8M
Roche Holding ROG:VX 8.6B 313M
Sarepta Therapeutics SRPT:US USD 202.68M 1.29M
Ultragenyx Pharmaceutical RARE:US USD 26.62M 150K
Vertex Pharmaceuticals VRTX:US USD 535.1M 74.5M